What additional reports will MyOme have in the near future?
We aim to continuously make new and updated reports available so patients' genetic risks can be leveraged–across a multitude of clinical conditions–to identify the next best steps for their health.
The MyOme platform unlocks a lifetime of health information from a single sample submission. Because we perform clinical-grade testing, we can re-analyze that single sample for future reports. We aim to continuously make new and updated reports available so patients' genetic risks can be leveraged–across a multitude of clinical conditions–to identify the next best steps for their health.